to investigate the effects of different treatment modalities , the composition and concentrations of fasting plasma lipoproteins were determined in a cross-sectional study of patients with type ii diabetes at diagnosis , treated by diet alone , treated by diet + glibenclamide ( 2.5 to 15 mg/d for 6 to 48 months ) , and treated by diet + insulin ( 25 to 65 u/d for 8 to 144 months ) .
C0011860
type ii diabetes
C0021641
insulin